"We design and develop next generation drug delivery formulations to improve patient care."

The joint laboratory of VRI and ReForm Therapeutics, Ltd. was estabilished in 2021 as a progression of an ongoing successful collaboration previous successfull collaboration in the area of the development of new candidate drug delivery systems for oromucosal administration. We replace traditional routes of drug administration by providing products with high added value for patients.

Design of innovative mucoadhesive formulations to improve drug bioavailability
Perform formulation feasibility studies
Conduct ex vivo testing
Carry out preclinical testing on various animal models including rabbits and pigs
Develop analytical methods for drug quantification
Drive candidate products into GMP production and clinical testing in colaboration progress with third parties